Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2661-2670 of 10669

Edit search filters
  1. BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

    Jacksonville, FL

  2. Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients with Brain Metastases that have been Removed by Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia

  4. Individualized Preoperative Rehabilitation Pilot

  5. Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)

    Rochester, MN

  6. Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice

    Rochester, MN

  7. Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)

    Rochester, MN

  8. Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

    Rochester, MN

  9. Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

    Rochester, MN

  10. Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction

    Rochester, MN

.

Mayo Clinic Footer